This post is also available in: Spanish

EFFICHRONIC - Polibienestar

The Final Conference of EFFICHRONIC will be held on November 18.

The main objective of this project is to determine the cost-effectiveness of the implementation of the “Chronic-disease self-mangement programme” (CDSMP) and to demonstrate its beneficial effects for the society. This training programme aims at vulnerable people suffering from one or more chronic diseases, and their caregivers. The key element of this training programme is to provide participants with strategies that allow them to self-manage their own health and disease, in order to be able to adapt the disease to their life, to face it and to adapt it to their individual and sociocultural environment, eventually improving their quality of life and their level of health. In the EFFICHRONIC project, the CDSMP has been implemented in five regions across Europe (Asturias, Rotterdam, Genoa, London and Montpellier).

Detailed information on the methodology used and the results obtained will be given at the conference. All EFFICHRONIC partners will participate to share their experience and learning.

In the morning session, experts in recruitment strategies, statistical analysis and Public Health policies will provide information on complementary studies of great interest carried out during the project.

In the afternoon session, Kate Lorig, main representative of the CDSMP programme, will discuss new challenges originated from the new COVID-19 pandemic and Jim Phillips, Co-director of the European Center for the Empowerment of Patients and Communities (CEMPAC), who will discuss the role of the health system in self-management strategies.

Registration is available here. Deadline for registration: 17 November 14:00h (CET)

The conference will be held virtually and registration is free of charge. Simultaneous translation will be available until 11:00 in the morning.

Final Conference Program
Final Conference Programme
This activity is part of the project EFFICHRONIC which has received funding from the European Union’s Health Programme (2014-2020). Ref: 738127.